Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.68 |
| ▸ | LMNA | P02545 | 3/20 | 0.68 |
| ▸ | CCR1 | P32246 | 3/20 | 0.68 |
| ▸ | CCR5 | P51681 | 3/20 | 0.68 |
| ▸ | CCR8 | P51685 | 3/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | METAP1 | P53582 | 1/20 | 0.68 |
| ▸ | BLM | P54132 | 1/20 | 0.68 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.68 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.68 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.68 |
| ▸ | NPC1 | O15118 | 8/20 | 0.65 |
| ▸ | TP53 | P04637 | 5/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | ALPL | P05186 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14067720 | 0.89 | KDM4E (0.55) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL13910995 | 0.87 | KDM4E (0.59) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL2061612 | 0.87 | KDM4E (0.70) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL7965339 | 0.85 | KDM4E (0.81) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL722577 | 0.85 | KDM4E (0.93) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL721272 | 0.85 | KDM4E (0.93) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL29467582 | 0.85 | KDM4E (0.93) | KDM4ELMNACCR1CCR5CCR8 | |
| Dipyridyl SCHEMBL3796795 | 0.85 | KDM4E (0.93) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL22761528 | 0.84 | KDM4E (0.55) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL176039 | 0.83 | KDM4E (0.68) | KDM4ELMNACCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119081361-A | Preparation of rare earth light conversion film and agricultural application thereof | 广西江和农业科技有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-116606639-A | Organic room temperature phosphorescent material with controllable afterglow performance and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2023-08-18 | — | — | CN | claimed |
| CN-112625068-B | Preparation, structure and fluorescence of heterobinuclear nickel-europium complex | 桂林理工大学 | 2022-09-30 | — | — | CN | claimed |
| US-8445475-B2 | Supramolecular complexes as photoactivated DNA cleavage agents | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2013-05-21 | — | — | US | claimed |
| US-8395003-B2 | Metal nanoparticle-based catalytic composition that contains a nitrogen-containing ligand in an ionic liquid, process for preparation, process for hydrogenation of an olefinic feedstock | IFP Energies Nouvelles (FR) | 2013-03-12 | — | — | US | claimed |
| US-8148360-B2 | Comprising at least one metal to ligand charge transfer (MLCT) light absorbing metal, at least one bridging ligand, and at least one platinum based DNA binding unit; complexes bind to DNA through platinum site then photocleave DNA; use in controlling hyperproliferating cells | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2012-04-03 | — | — | US | claimed |
| US-20100228064-A1 | PROCESS FOR HYDROGENATION OF AN AROMATIC FEEDSTOCK THAT AS CATALYST USES A SUSPENSION OF METAL NANOPARTICLES CONTAINING A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID | IFP (FR) | 2010-09-09 | — | — | US | claimed |
| US-20100191027-A1 | METAL NANOPARTICLE-BASED CATALYTIC COMPOSITION THAT CONTAINS A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID, PROCESS FOR PREPARATION, PROCESS FOR HYDROGENATION OF AN OLEFINIC FEEDSTOCK | IFP (FR) | 2010-07-29 | — | — | US | claimed |
| US-20100047910-A1 | SUPRAMOLECULAR COMPLEXES AS PHOTOACTIVATED DNA CLEAVAGE AGENTS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2010-02-25 | — | — | US | claimed |
| US-20090061336-A1 | LIGHT STABILIZER CONTAINING PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-03-05 | — | — | US | claimed |
| EP-1718590-A1 | CATALYST SYSTEM FOR AEOROBIC OXIDATION OF PRIMARY AND SECONDARY ALCOHOLS. | The NutraSweet Company (US) | 2006-11-08 | — | — | EP | claimed |
| US-20050272713-A1 | Supramolecular complexes as photoactivated DNA cleavage agents | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. | 2005-12-08 | — | — | US | claimed |
| US-6962910-B2 | ((2,2'-bipyridine)2Os(2,3-bis(2-pyridyl)pyrazine)RhCl2(2,3-bis(2 -pyridyl) pyrazine) Os(2,2'-bipyridine)2)(X)5, where X is a counterion selected from PF6-, CL-, BR-, CF3SO3- and BF4- a supramolecular metal complex; photodynamic therapy | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2005-11-08 | — | — | US | claimed |
| WO-2005082825-A1 | CATALYST SYSTEM FOR AEOROBIC OXIDATION OF PRIMARY AND SECONDARY ALCOHOLS. | THE NUTRASWEET COMPANY (US) | 2005-09-09 | — | — | WO | claimed |
| US-20030180767-A1 | Supramolecular complexes as photoactivated DNA cleavage agents | VIRGINIA POLYTECHNIC INSTITUTE & STATE UNIVERSITY | 2003-09-25 | — | — | US | claimed |
| WO-2003002119-A1 | TREATMENT AND PREVENTION OF LIPODERMATOSCLEROSIS | JOHNSON & JOHNSON MEDICAL LIMITED (GB) | 2003-01-09 | — | — | WO | claimed |
| US-5780459-A | SALICYLIC ACID WITH ADDITIONAL ACTIVE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-14 | — | — | US | claimed |
| US-5487884-A | CYTOPROTECTIVE AGENTS BY RADIATION RESISTANCE TO PREVENT SKIN CANCER AND PREMATURE AGING | THE PROCTER & GAMBLE COMPANY (US) | 1996-01-30 | — | — | US | claimed |
| US-5320969-A | Measuring the change in color when complexing a metal compound and colored indicator in a buffered solution of biological sample, e.g. urine | MILES INC. (US) | 1994-06-14 | — | — | US | claimed |
| EP-0313305-A2 | Photoprotection compositions comprising chelating agents | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100228064-A1 | PROCESS FOR HYDROGENATION OF AN AROMATIC FEEDSTOCK THAT AS CATALYST USES A SUSPENSION OF METAL NANOPARTICLES CONTAINING A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID | SET, NCL, TNK1 | KDM4E 698/4885LMNA 2721/4885CCR1 3006/4885 |
| US-20100191027-A1 | METAL NANOPARTICLE-BASED CATALYTIC COMPOSITION THAT CONTAINS A NITROGEN-CONTAINING LIGAND IN AN IONIC LIQUID, PROCESS FOR PREPARATION, PROCESS FOR HYDROGENATION OF AN OLEFINIC FEEDSTOCK | NCL, C9, ARG1 | KDM4E 2293/4885LMNA 2898/4885CCR1 887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.